Liquidity & Technical

Liquidity & Technical

Figures converted from INR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, percentages, RSI, MACD, and volatility readings are unitless and unchanged.

Groww is institutionally tradable on size — five-day capacity at 20% participation clears $165.4 million, equivalent to roughly 1.37% of market cap, so a 5% portfolio position is implementable for funds up to about $3.3 billion AUM. The tape, however, has just broken: price has lost 19% in 12 sessions, RSI has collapsed from 77 to 38 in three weeks, MACD turned bearish on 7 May, and today's session printed an 11x-volume distribution day through the lower Bollinger band — short-term momentum is decisively negative even though the six-month uptrend off the IPO has not yet been invalidated.

1. Portfolio implementation verdict

2. Price snapshot

The stock has compounded since its 12 November 2025 IPO debut ($1.46), peaked at $2.38 on 23 April, and given back nearly 20% in the three weeks since. Beta is not yet meaningful — six months of post-IPO trading does not produce a stable factor loading.

3. The critical chart — price and moving averages

Price is fractionally above the 50-day ($1.92 vs $1.91) and roughly 6% above the 100-day ($1.81), but 13% below the 20-day ($2.20). Today's close also pierced the lower Bollinger band at $1.99. The intermediate uptrend off the IPO is intact; the short-term trend has decisively broken. Read this as a corrective phase inside a young uptrend — not a structural top — until the 100-day at $1.81 gives way.

4. Relative strength

The packaged relative-performance file carries no benchmark series for Groww — the broad-market and sector ETF baskets came back empty in this run (manifest defaults to SPY, which is irrelevant for an NSE listing). With only six months of post-IPO history and a recent rally that ran 70% off the December low before reversing, a relative-strength read against NIFTY 50 or NIFTY Financial Services would be the right diagnostic; we cannot produce one here without resampling that data. Treat the absolute price action above as the only defensible read.

5. Momentum — RSI and MACD histogram

Momentum is the clearest signal in this tape. RSI rocketed from 39 (6 March) to 78 (15 April) on the breakout rally, then collapsed 40 points in three weeks — that is one of the fastest decelerations available in the post-IPO record. The MACD histogram hit a +4.97 peak in mid-April and is now at −4.85, with the MACD line (4.41) cleanly below signal (9.26) since 7 May. The single most actionable observation: RSI at 38 is approaching oversold but is not there yet, while MACD is still extending lower — meaning the bounce has not been earned, and the more likely near-term path is one more leg down or a sideways base before any recovery.

6. Volume, volatility, and sponsorship

The top three volume spikes since the IPO splash tell the entire story of this past month: the 15 April and 21 April sessions were up-side breakout days on 4–8x volume that drove the rally to $2.38, and the 12 May session is an 11x distribution day that printed −5.4%. Conviction has flipped sides. Sponsorship that built the breakout has now exited it.

Realized vol at 62.6% sits above the p80 band of 55% — formally a stressed regime versus the (admittedly short) post-IPO sample. The median session range over the last 60 days is 4.1%, which is roughly double the threshold at which trading-friction concerns kick in for large orders; a slicing execution mandate is required even at the 5-day capacity sizes shown below.

7. Institutional liquidity panel

Read the manifest carefully — it reports liquidity_verdict: "Liquidity unknown" because the underlying liquidity file did not have shares-outstanding pre-populated. The market-cap field is available from the company snapshot ($12.05 billion), so we are recomputing the issuer-level numbers below.

The 20-day ADV is running roughly 80% above the 60-day ADV (86M vs 47M shares per day), almost entirely a function of the April rally and today's 542M-share session — i.e. liquidity is currently elevated by event flow rather than a stable institutional base.

The 60-day median daily range is 4.1%, materially above the 2% threshold at which intraday impact cost becomes a real drag on institutional orders — sizing assumptions should incorporate a wider implementation-shortfall budget than for a typical large-cap NSE name. Verdict: a 1%-of-issuer position ($120.5M / 62.7M shares) clears the 5-day threshold at 20% participation in 4 sessions; under the more conservative 10% participation, the same position needs 8 sessions and a 0.5%-of-issuer position is the appropriate ceiling. For most generalist funds, this stock is institutionally implementable — capacity is not the bottleneck.

8. Technical scorecard and stance

Stance: cautious on the 3-to-6 month tape (total technical score −3). The breakout that ran price from $1.67 to $2.38 between 6 March and 23 April has now reversed faster than it was built, and the May 12 distribution day on 11x volume is the kind of session that more often opens a corrective phase than ends one. The setup points to a likely test of the 100-day at $1.81 (also the February floor) before any durable basing pattern forms. Two levels frame the read: a sustained close back above $2.20 — which reclaims the 20-day and the April breakout zone — flips the tape constructive; a close below $1.80 breaks the 100-day and the February base in a single move and would confirm a deeper correction. Liquidity is not the constraint; timing is — a 5% position is buildable for funds up to ~$3.3 bn AUM at 20% ADV participation, but the natural action today is watchlist with a staged build only on a confirmed reclaim of $2.20 or a successful test-and-hold of $1.80.

Caveat: Groww is a six-month-old listing (IPO 12 November 2025). The 200-day SMA, one-year return, and stable beta are all unavailable. Treat all technical conclusions here as short-cycle reads on a tape that has not yet built a structural history.